Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17174 (
aspartate aminotransferase
)
14,872
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 72-year-old woman with
von Recklinghausen's disease
was referred to our hospital because of pain and muscle weakness in her thighs. She had elevated serum values of creatine kinase,
aspartate aminotransferase
, alanine aminotransferase, lactate dehydrogenase, and aldolase. Based on these results, a diagnosis of polymyositis was made. Treatment with prednisolone improved muscle strength, and laboratory values returned to normal. Computed tomography, magnetic resonance imaging of the abdomen, and 131I-metaiodobenzyl guanidine MIBG scintigraphy demonstrated a tumor 3 cm in diameter in the region of the left adrenal gland. Endocrinologic investigation disclosed elevation of serum and urine catecholamines. Since the blood pressure was normal, nonfunctioning pheochromocytoma was diagnosed clinically. The nonhypertensive course was attributed to reduced vascular response to noradrenaline. Serum lactate dehydrogenase. alkaline phosphatase. and asparate aminotransferase became elevated, and abdominal computed tomography showed a well-defined mass measuring 13 x 12 x 10 cm in the right lobe of the liver. The patient underwent right trisegmentectomy and left adrenalectomy. Histologically the adrenal tumor was a typical pheochromocytoma. The hepatic tumor was a leiomyosarcoma consisting of elongated spindle-shaped atypical cells arranged in intersecting bundles. Immunohistochemically, the cells of this tumor were reactive for alpha-smooth muscle actin and vimentin. The leiomyosarcoma recurred and metastasized to the liver. Eight months after onset of symptom, the patient developed hepatic coma and died. The mean age at presentation with pheochromocytoma in
von Recklinghausen's disease
patients age is 42 years. Our patient was considerably older. To the best of our knowledge this is the first report of a patient with
von Recklinghausen's disease
developing polymyositis. asymptomatic pheochromocytoma, and primary hepatic leiomyosarcoma and illustrates the need to remain aware of the possibility of cancer in
von Recklinghausen's disease
.
...
PMID:[A patient with von Recklinghausen's disease associated with polymyositis, asymptomatic pheochromocytoma, and primary hepatic leiomyosarcoma]. 1523 55
Neurofibromatosis type 1
(
NF1
) has many reported clinical characteristics. We previously found that
NF1
patients (especially men) had lower body mass index (BMI) than controls, but the reason has not been elucidated. To address this issue, a retrospectively case-control study was conducted. Anthropometric and serum chemistry data that potentially relate to BMI were collected from medical records of
NF1
patients and their age- and sex-matched controls. Enrollment of 98 adult patients who underwent skin surgery with
NF1
(41 men, 57 women) and 173 without
NF1
(74 men, 99 women) were investigated. The median BMI in male
NF1
patients was significantly lower than that of the controls. Triglycerides in male
NF1
patients were significantly lower than male controls, creatine kinase and lactate dehydrogenase in
NF1
patients were also lower than controls,
aspartate aminotransferase
and alanine aminotransferase showed a lower tendency in
NF1
patients, but were significantly lower in female patients. With correlation analysis, lactate dehydrogenase was moderately correlated with BMI in male
NF1
patients. Creatine kinase and creatinine showed no statistical correlation with BMI in either group. Triglycerides and alanine aminotransferase showed a positive correlation with BMI in both male and female controls, but not in
NF1
patients. In conclusion, only lactate dehydrogenase was moderately correlated with BMI in male
NF1
patients, although results of some nutritional and metabolic parameters suggest a specific metabolism in
NF1
.
...
PMID:Nutritional, muscular and metabolic characteristics in patients with neurofibromatosis type 1. 2670 55